A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates

References

• Farmer PB. Metabolism and reactions of alkylating agents. Pharmacol Ther 1987;35:301–58
   PubMed Web of Science ®Google Scholar
• Rothbarth J, Koevoets C, Tollenaar RA, et al. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo. Biochem Pharmacol 2004;67:1771–8
   PubMed Web of Science ®Google Scholar
• Cozzi P. The discovery of a new potential anticancer drug: a case history. Il Farmaco 2003;58:213–20
   PubMedGoogle Scholar
• Denny WA. DNA minor groove alkylating agents. Curr Med Chem 2001;8:533–44
   PubMed Web of Science ®Google Scholar
• Bartulewicz D, Bielawski K, Bielawska A, Rozanski A. Synthesis, molecular modelling, and antiproliferative and cytotoxic effects of carbocyclic derivatives of distamycin with chlorambucil moiety. Eur J Med Chem 2001;36:461–7
   PubMed Web of Science ®Google Scholar
• Haddow A, Timmis GM. Myleran in chronic myeloid leukaemia; chemical constitution and biological action. Lancet 1953;264:207–8
   PubMed Web of Science ®Google Scholar
• Knock FE. Newer anticancer agents. Med Clin N Am 1964;48:501–27
   PubMed Web of Science ®Google Scholar
• Hanada K, Budzowska M, Modesti M, et al. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J 2006;25:4921–32
   PubMed Web of Science ®Google Scholar
• Valdez BC, Nieto Y, Murray D, et al. Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines. Exp Hematol 2012;40:800–10
   PubMed Web of Science ®Google Scholar
• Brookes P, Lawley PD. Reaction of some mutagenic and carcinogenic compounds with nucleic acids. J Cell Comp Physiol 1964;64:111–28
   Google Scholar
• Li S, Wang X, He Y, et al. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer. Eur J Med Chem 2013;67:293–301
   PubMed Web of Science ®Google Scholar
• Arias JL, López-Viota M, Gallardo V, Ruiz MA. Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur. Drug Dev Ind Pharm 2010;36:744–50
   PubMed Web of Science ®Google Scholar
• Nagamine MK, da Silva TC, Matsuzaki P, et al. Cytotoxic effects of butanolic extract from Pfaffia paniculata (Brazilian ginseng) on cultured human breast cancer cell line MCF-7. Exp Toxicol Pathol 2009;61:75–82
   PubMed Web of Science ®Google Scholar
• Valizadeh H, Ghanbarzadeh S, Zakeri-Milani P. Fusogenic liposomal formulation of sirolimus: improvement of drug anti-proliferative effect on human T-cells. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.971032
   Web of Science ®Google Scholar
• Soule HD, Vazguez J, Long A, et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973;51:1409–16
   PubMed Web of Science ®Google Scholar
• Natarajan N, Thamaraiselvan R, Lingaiah H, et al. Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7. Biomed Prev Nutr 2011;1:207–15
   Google Scholar
• Hennink WE, van Nostrum CF. Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev 2012;64:223–36
   Web of Science ®Google Scholar
• Sallam MA, Motawaa AM, Mortada SM. An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion. Drug Dev Ind Pharm 2015;41:141–7
   PubMed Web of Science ®Google Scholar
• Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001;101:1869–79
   PubMed Web of Science ®Google Scholar
• Kopecek J. Hydrogels from soft contact lenses and implants to self-assembled nanomaterials. J Polym Sci Part A, Polym Chem 2009;47:5929–46
   PubMed Web of Science ®Google Scholar
• Itoh K, Kubo W, Fujiwara M, et al. The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations. Int J Pharm 2006;312:37–42
   PubMed Web of Science ®Google Scholar
• Shim WS, Kim J-H, Kim K, et al. pH-and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel. Int J Pharm 2007;331:11–18
   PubMed Web of Science ®Google Scholar
• Ko DY, Shinde UP, Yeon B, Jeong B. Recent progress of in situ formed gels for biomedical applications. Prog Polym Sci 2013;38:672–701
   Web of Science ®Google Scholar
• Mohd Amin MCI, Ahmad N, Pandey M, Jue Xin C. Stimuli-responsive bacterial cellulose-g-poly(acrylic acid-co-acrylamide) hydrogels for oral controlled release drug delivery. Drug Dev Ind Pharm 2014;40:1340–9
   PubMed Web of Science ®Google Scholar
• Xu Y, Shen Y, Xiong Y, et al. Synthesis, characterization, biodegradability and biocompatibility of a temperature-sensitive PBLA-PEG-PBLA hydrogel as protein delivery system with low critical gelation concentration. Drug Dev Ind Pharm 2014;40:1264–75
   PubMed Web of Science ®Google Scholar
• Hoffman AS. Applications of thermally reversible polymers and hydrogels in therapeutics and diagnostics. J Control Release 1987;6:297–305
   Google Scholar
• Peppas NA, Klier J. Controlled release by using poly (methacrylic acid-g-ethylene glycol) hydrogels. J Control Release 1991;16:203–14
   Web of Science ®Google Scholar
• Chen G, Hoffman AS. Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH. Nature 1995;373:49–52
   PubMed Web of Science ®Google Scholar
• Ajazuddin, Alexander A, Khan J, et al. Advancement in stimuli triggered in situ gelling delivery for local and systemic route. Expert Opin Drug Deliv 2012;9:1573–92
   PubMed Web of Science ®Google Scholar
• Liu Z, Calvert P. Multilayer hydrogels as muscle-like actuators. Adv Mater 2000;12:288–91
   Web of Science ®Google Scholar
• Kim SJ, Yoon SG, Lee YM, Kim SI. Electrical sensitive behavior of poly (vinyl alcohol)/poly (diallyldimethylammonium chloride) IPN hydrogel. Sensor Actuat B: Chem 2003;88:286–91
   Web of Science ®Google Scholar
• Bromberg LE, Ron ES. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev 1998;31:197–221
   PubMed Web of Science ®Google Scholar
• Alexander A, Ajazuddin, Khan J, et al. Polyethylene glycol (PEG)–poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications. Eur J Pharm Biopharm 2014;88:575–85
   PubMed Web of Science ®Google Scholar
• Alexander A, Ajazuddin, Khan J, et al. Poly(ethylene glycol)–poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications. J Control Release 2013;172:715–29
   PubMed Web of Science ®Google Scholar
• Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects – an update. J Pharm Pharmacol 2001;53:1047–67
   PubMed Web of Science ®Google Scholar
• Hasanovic A, Zehl M, Reznicek G, Valenta C. Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability. J Pharm Pharmacol 2009;61:1609–16
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, SchÄTzlein AG, Tetley L, et al. Polymeric chitosan-based vesicles for drug delivery. J Pharm Pharmacol 1998;50:453–8
   PubMed Web of Science ®Google Scholar
• Çelebi N, Ermiş S, Özkan S. Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.891129
   PubMed Web of Science ®Google Scholar
• Tan ML, Choong PFM, Dass CR. Cancer, chitosan nanoparticles and catalytic nucleic acids. J Pharm Pharmacol 2009;61:3–12
   PubMed Web of Science ®Google Scholar
• Albasarah YY, Somavarapu S, Stapleton P, Taylor KM. Chitosan-coated antifungal formulations for nebulisation. J Pharm Pharmacol 2010;62:821–8
   PubMed Web of Science ®Google Scholar
• Chenite A, Chaput C, Wang D, et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000;21:2155–61
   PubMed Web of Science ®Google Scholar
• Xuan J-J, Balakrishnan P, Oh DH, et al. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. Int J Pharm 2010;395:317–23
   PubMed Web of Science ®Google Scholar
• Chen X, Zhi F, Jia X, et al. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. J Pharm Pharmacol 2013;65:807–16
   PubMed Web of Science ®Google Scholar
• Al-Saden A, Florence AT, Whateley TL. Novel poloxamer (pluronic) and poloxamine (tetronic) hydrogels: swelling and drug release. J Pharm Pharmacol 1980;32:5P
   Google Scholar
• Ajazuddin, Alexander A, Amarji B, Kanaujia P. Synthesis, characterization and in vitro studies of pegylated melphalan conjugates. Drug Dev Ind Pharm 2013;39:1053–62
   PubMed Web of Science ®Google Scholar
• Alexander A, Ajazuddin, Khan J, et al. Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate. J Pharm Pharmacol 2014;66:1240–50
   PubMed Web of Science ®Google Scholar
• Schmolka IR. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1972;6:571–82
   PubMed Web of Science ®Google Scholar
• Cardile V, Renis M, Scifo C, et al. Behaviour of the new asbestos amphibole fluoro-edenite in different lung cell systems. Int J Biochem Cell Biol 2004;36:849–60
   PubMed Web of Science ®Google Scholar
• Ta HT, Dass CR, Larson I, et al. A chitosan–dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma. Biomaterials 2009;30:3605–13
   PubMed Web of Science ®Google Scholar
• Nasir F, Iqbal Z, Khan A, et al. Development and evaluation of pluronic-and methylcellulose-based thermoreversible drug delivery system for insulin. Drug Dev Ind Pharm 2014;40:1503–8
   PubMed Web of Science ®Google Scholar
• Gao M, Xu H, Zhang C, et al. Preparation and characterization of curcumin thermosensitive hydrogels for intratumoral injection treatment. Drug Dev Ind Pharm 2014;40:1557–64
   PubMed Web of Science ®Google Scholar